Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nasopharyngeal Neoplasms × penpulimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1 Carcinoma 1 Breast Neoplasms 1 Breast Neoplasm Female 1

Interventions

Cisplatin 15 Radiotherapy 8 Fluorouracil 8 Gemcitabine 7 Docetaxel 7 Paclitaxel 6 Oxaliplatin 4 Carboplatin 4 Capecitabine 4 Endostatins 3 Bevacizumab 3 spartalizumab 2 pembrolizumab 2 endostar protein 2 apatinib 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Cetuximab 2 Celecoxib 2 triethanolamine 1 toripalimab 1 sintilimab 1 regramostim 1 penpulimab 1 infigratinib 1 fluzoparib 1 cc-486 1 camrelizumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05807880 2026-01-23

ALTER-HN005

Sun Yat-sen University

Phase 2 Active not recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡